pamba administered orally ( 1.0 g ) was found to reduce significantly the maximal change in fev1 , pef following challenge in patients with analgesic-induced asthma ( n = 30 ; p less than or equal to 0.01 ) , exercise-induced asthma ( n = 37 ; p less than or equal to 0.01 ) or allergen-induced asthma ( n = 7 ; p less than or equal to 0.05 ) .
C0004099
exercise-induced asthma
C0004096
asthma